BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 7766658)

  • 1. Subcellular localization of 12(S)-hydroxy-5,8,10,14-eicosatetraenoic acid binding sites in Lewis lung carcinoma cells.
    Herbertsson H; Hammarström S
    Biochim Biophys Acta; 1995 May; 1244(1):191-7. PubMed ID: 7766658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytosolic 12(S)-hydroxy-5,8,10,14-eicosatetraenoic acid binding sites in carcinoma cells.
    Herbertsson H; Hammarström S
    Adv Exp Med Biol; 1997; 400A():287-93. PubMed ID: 9547570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A 12(S)-hydroxyeicosatetraenoic acid receptor interacts with steroid receptor coactivator-1.
    Kurahashi Y; Herbertsson H; Söderström M; Rosenfeld MG; Hammarström S
    Proc Natl Acad Sci U S A; 2000 May; 97(11):5779-83. PubMed ID: 10823935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-affinity binding sites for 12(S)-hydroxy-5,8,10,14-eicosatetraenoic acid (12(S)-HETE) in carcinoma cells.
    Herbertsson H; Hammarström S
    FEBS Lett; 1992 Feb; 298(2-3):249-52. PubMed ID: 1544456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of subunits of the 650 kDa 12(S)-HETE binding complex in carcinoma cells.
    Herbertsson H; Kühme T; Evertsson U; Wigren J; Hammarström S
    J Lipid Res; 1998 Feb; 39(2):237-44. PubMed ID: 9507984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The 650-kDa 12(S)-hydroxyeicosatetraenoic acid binding complex: occurrence in human platelets, identification of hsp90 as a constituent, and binding properties of its 50-kDa subunit.
    Herbertsson H; Kühme T; Hammarström S
    Arch Biochem Biophys; 1999 Jul; 367(1):33-8. PubMed ID: 10375396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor cell-derived 12(S)-hydroxyeicosatetraenoic acid induces microvascular endothelial cell retraction.
    Honn KV; Tang DG; Grossi I; Duniec ZM; Timar J; Renaud C; Leithauser M; Blair I; Johnson CR; Diglio CA
    Cancer Res; 1994 Jan; 54(2):565-74. PubMed ID: 8275495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 12(S)-hydroxyeicosatetraenoic acid and 13(S)-hydroxyoctadecadienoic acid regulation of protein kinase C-alpha in melanoma cells: role of receptor-mediated hydrolysis of inositol phospholipids.
    Liu B; Khan WA; Hannun YA; Timar J; Taylor JD; Lundy S; Butovich I; Honn KV
    Proc Natl Acad Sci U S A; 1995 Sep; 92(20):9323-7. PubMed ID: 7568126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-affinity binding and lack of growth-promoting activity of 12(S)-hydroxyeicosatetraenoic acid (12(S)-HETE) in a human epidermal cell line.
    Gross E; Ruzicka T; von Restorff B; Stolz W; Klotz KN
    J Invest Dermatol; 1990 Apr; 94(4):446-51. PubMed ID: 2313116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of microvascular endothelium by eicosanoid 12(S)-hydroxyeicosatetraenoic acid leads to enhanced tumor cell adhesion via up-regulation of surface expression of alpha v beta 3 integrin: a posttranscriptional, protein kinase C- and cytoskeleton-dependent process.
    Tang DG; Diglio CA; Honn KV
    Cancer Res; 1994 Feb; 54(4):1119-29. PubMed ID: 8313370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The lipoxygenase metabolite 12(S)-HETE induces a cytoskeleton-dependent increase in surface expression of integrin alpha IIb beta 3 on melanoma cells.
    Chopra H; Timar J; Chen YQ; Rong XH; Grossi IM; Fitzgerald LA; Taylor JD; Honn KV
    Int J Cancer; 1991 Nov; 49(5):774-86. PubMed ID: 1937964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of specific subcellular 15-hydroxyeicosatetraenoic acid (15-HETE) binding sites on rat basophilic leukemia cells.
    Kang LT; Vanderhoek JY
    Biochim Biophys Acta; 1995 Jun; 1256(3):297-304. PubMed ID: 7786891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of high-affinity 12(S)-hydroxyeicosatetraenoic acid (12(S)-HETE) binding sites on normal human keratinocytes.
    Arenberger P; Kemény L; Ruzicka T
    Epithelial Cell Biol; 1993 Jan; 2(1):1-6. PubMed ID: 8394769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of ciclosporin on epidermal 12(S)-hydroxyeicosatetraenoic acid binding sites.
    Arenberger P; Ruzicka T; Kemény L
    Skin Pharmacol; 1991; 4(4):272-7. PubMed ID: 1789988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of 12(S)-hydroxyeicosatetraenoic acid (12(S)-HETE) binding sites on human epidermal cells by interferon-gamma.
    Süss R; Arenberger P; Gross EC; Ruzicka T
    Exp Cell Res; 1990 Dec; 191(2):204-8. PubMed ID: 2175266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 12(S)-HETE enhancement of prostate tumor cell invasion: selective role of PKC alpha.
    Liu B; Maher RJ; Hannun YA; Porter AT; Honn KV
    J Natl Cancer Inst; 1994 Aug; 86(15):1145-51. PubMed ID: 7518003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Localization of 12-hydroxyeicosatetraenoic acid in endothelial cells.
    Wang LX; Kaduce TL; Spector AA
    J Lipid Res; 1990 Dec; 31(12):2265-76. PubMed ID: 2090720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biosynthesis of 12(S)-hydroxyeicosatetraenoic acid by B16 amelanotic melanoma cells is a determinant of their metastatic potential.
    Liu B; Marnett LJ; Chaudhary A; Ji C; Blair IA; Johnson CR; Diglio CA; Honn KV
    Lab Invest; 1994 Mar; 70(3):314-23. PubMed ID: 8145526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Langerhans cells of the human skin possess high-affinity 12(S)-hydroxyeicosa tetraenoic acid receptors.
    Arenberger P; Kemény L; Rupec R; Bieber T; Ruzicka T
    Eur J Immunol; 1992 Sep; 22(9):2469-72. PubMed ID: 1325349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The lipoxygenase inhibitor 2-phenylmethyl-1-naphthol (DuP 654) is a 12(S)-hydroxyeicosatetraenoic acid receptor antagonist in the human epidermal cell line SCL-II.
    Arenberger P; Raap A; Armah B; Kemény L; Ruzicka T
    Skin Pharmacol; 1993; 6(2):148-51. PubMed ID: 8394724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.